CIK 0001615219 · Non-accelerated filer<br>Smaller reporting company
Decoy Therapeutics Inc.
Sign in to watch- Ticker
- DCOY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465087339
- Phone
- 346-772-0346
- Business address
- 2450 HOLCOMBE BLVD, SUITE J-608, HOUSTON, TX, 77021
- Former names
- Salarius Pharmaceuticals, Inc., Flex Pharma, Inc.
- 4 Grant or award Director acquired 2,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 33,455 shares (grant or award)
- 4 Grant or award Chief Business Officer acquired 3,900 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 9,682 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 4,216 shares (grant or award)
- 4 Grant or award Director acquired 3,000 shares (grant or award)
- 4 Grant or award Director acquired 2,000 shares (grant or award)
- 4 Grant or award Director acquired 2,000 shares (grant or award)
- 4 Grant or award Director acquired 3,000 shares (grant or award)
- 4 Grant or award Director acquired 2,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 27 shares at $0.64 ($17)
- 4 Open-market buy Director bought 5,000 shares at $0.75 ($3,741)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Exec VP Finance, CFO bought 20,000 shares at $0.80 ($16,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 1 of 15 · 284 filings